Predicting malignancy in patients with adrenal tumors using 18 F-FDG-PET/CT SUVmax.
Elvira L VosRavinder K GrewalAshley E RussoDiane Reidy-LagunesBrian R UntchSomali C GavaneLaura BoucaiEliza GeerAnuradha GopalanJoanne F ChouMarinela CapanuVivian E StrongPublished in: Journal of surgical oncology (2020)
18 F-FDG-PET/CT SUVmax was associated with malignancy. Validation indicated that SUVmax ≥ 4.6 was suggestive of malignancy, while lower values did not reliably predict benign tumor.
Keyphrases